Doctor profile · Federal record
Dr. Maja Matwiejczuk, FNP APRN
Nurse Practitioner · Enfield, CT
- NPI 1093276750
- Accepts Medicare
- 8 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
113 Elm Street, Suite 304
Enfield, CT 06082
(860) 741-2225
fax (860) 741-2229
Credentials & registration
- NPI registered
- March 2019 — 7 yrs on file
- Profile last updated
- August 11, 2021
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Connecticut #8143
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1093276750. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,074
Distinct HCPCS
9
Medicare allowed
$74,323
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 383 | 81 | $6 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 246 | 203 | $116 | |
17000 |
Destruction of precancer skin growth, 1 growth | 142 | 121 | $55 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 75 | 75 | $152 | |
11102 |
Biopsy of related skin growth, first growth | 74 | 67 | $91 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 55 | 48 | $82 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 45 | 34 | $158 | |
17110 |
Destruction of skin growth, 1-14 growths | 42 | 37 | $107 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 12 | 12 | $102 |
In context: peer comparison
Among 3 peers in Enfield Nurse Practitioner, average services per provider: 80. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$2,130
Transactions
137
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 23 | $481.35 | |
| E.R. Squibb & Sons, L.L.C. | 21 | $358.30 | |
| Abbvie INC. | 20 | $347.56 | |
| Novartis Pharmaceuticals Corporation | 22 | $200.02 | |
| Ucb, INC. | 21 | $194.86 | |
| Arcutis Biotherapeutics, INC. | 17 | $165.64 | |
| Regeneron Healthcare Solutions, INC. | 1 | $99.26 | |
| Genzyme Corporation | 2 | $70.69 | |
| Pfizer INC. | 3 | $56.24 | |
| Incyte Corporation | 2 | $54.73 | |
| Lilly USA, LLC | 1 | $26.32 | |
| Sun Pharmaceutical Industries INC. | 1 | $25.41 | |
| Amgen INC. | 1 | $18.53 | |
| Leo Pharma INC. | 1 | $16.81 | |
| Galderma Laboratories, L.P. | 1 | $14.57 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
867
Patients
582
Total drug cost
$117,233
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 363 | 235 | $6,842 |
| Triamcinolone Acetonide | Generic | 132 | 107 | $1,641 |
| Hydrocortisone | Generic | 72 | 60 | $522 |
| Ammonium Lactate | Generic | 46 | 35 | $1,023 |
| Betamethasone Dipropionate | Generic | 46 | 34 | $2,655 |
| Mupirocin | Generic | 44 | 35 | $343 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 31 | 11 | $855 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 27 | 19 | $310 |
| Metronidazole | Generic | 21 | 16 | $1,838 |
| Fluorouracil | Generic | 19 | 17 | $1,723 |
Frequently asked questions
What is Dr. Maja Matwiejczuk's medical specialty?
Dr. Maja Matwiejczuk practices Nurse Practitioner in Enfield, CT.
Where does Dr. Maja Matwiejczuk practice?
Dr. Maja Matwiejczuk practices at 113 Elm Street, Enfield, CT 06082. Office phone: 8607412225.
What is Dr. Maja Matwiejczuk's NPI?
Dr. Maja Matwiejczuk's National Provider Identifier (NPI) is 1093276750, issued by NPPES.
Does Dr. Maja Matwiejczuk accept Medicare assignment?
Yes. Dr. Maja Matwiejczuk accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Maja Matwiejczuk commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.